Page last updated: 2024-11-07

carbachol and Neuroectodermal Tumors, Primitive, Peripheral

carbachol has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Neuroectodermal Tumors, Primitive, Peripheral: A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with EWING SARCOMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, AS1
Yeung, WW1
Wong, YH1
Lobaugh, LA1
Blackshear, PJ1

Other Studies

2 other studies available for carbachol and Neuroectodermal Tumors, Primitive, Peripheral

ArticleYear
Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells.
    Journal of neurochemistry, 2005, Volume: 94, Issue:5

    Topics: Adenylyl Cyclases; Brain Neoplasms; Calcium Signaling; Carbachol; Cyclic AMP Response Element-Bindin

2005
Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
    The American journal of physiology, 1990, Volume: 258, Issue:5 Pt 1

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Animals; Binding, Competitive; Carbachol; Cell

1990